Navigation Links
goBalto, Inc. Names Sujay Jadhav as Its New CEO
Date:12/4/2013

SAN FRANCISCO, Dec. 4, 2013 /PRNewswire/ -- goBalto, Inc. announced today the appointment of Sujay Jadhav as Chief Executive Officer. Jae Chung, former CEO and founder, will manage corporate strategy, sales, and business development as President.

This appointment positions goBalto for accelerated sales in domestic markets and globally. With an increasing customer base in top pharma and CROs, and planned expansion into international markets, Jadhav's experience integrating software development, life sciences, and corporate strategy is ideally suited to help strengthen goBalto's market leadership.

Most recently, Jadhav was Senior VP of Global Corporate Strategy and Development at Model N, where he led corporate development and life sciences, analytics, and SaaS business units. He was employee #6 and instrumental in the growth of Model N to 600 employees, over $100M in revenue, and its eventual IPO (NYSE: MODN). His career includes strategy consulting at Booz Allen Hamilton, product strategy at CommerceOne, and general management at Singapore Telecom.

Jadhav received his undergraduate degree from the University of South Australia and an MBA from Harvard Business School.

"I'm honored and delighted to lead goBalto into becoming a recognized global brand. This is a unique opportunity to transform an industry through technology. goBalto's talented team and groundbreaking product are poised to make a difference, and I'm excited to grow the company into a market leader," said Jadhav.

"I founded goBalto 5 years ago on the principle that the life sciences industry should not accept the status quo in how clinical studies are started," said Chung. "Our vision has resonated with numerous leading biopharmaceutical companies and CROs, resulting in strong demand for our cloud-based solution – Tracker 2.0. I'm pleased Sujay is joining team goBalto as our CEO. With Sujay at the helm, I know we'll grow into a world-class solutions provider to tackle the complex terrain of clinical study startup and beyond."

About goBalto
goBalto develops next-generation solutions that simplify how clinical trials are started in the pharmaceutical, biotechnology, and medical device industries. Our flagship product, Tracker, is a purpose-built software-as-a-service clinical research platform. It enables clinical trial sponsors and research organizations to track milestones on the critical path, and provides document workflow management capabilities in a transparent, regulatory-compliant, and user-friendly way. Founded in 2008 in Silicon Valley by biotechnology industry veteran Jae Chung, goBalto is backed by leading health technology investors. For more information, visit www.gobalto.com.

Contact: Maria Breaux, 415-994-5040, mbreaux@gobalto.com


'/>"/>
SOURCE goBalto, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. goBalto, Inc. expands Tracker 2.0s analytics and submissions features
2. Aptuit Names Jonathan Goldman As CEO
3. 3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
4. Seno Medical Instruments Names Dr. Thomas Stavros Medical Director
5. CVS Caremark Names Tracy Bahl as Executive Vice President, Health Plans
6. GrandCare Systems Names Daniel Maynard As New Chief Executive Officer
7. Catabasis Names Ian Sanderson Chief Financial Officer
8. Imprimis Pharmaceutical Names Seasoned Ophthalmology Executive John Saharek as Vice-President of Commercialization for its Ophthalmology Division
9. Accelerate Diagnostics, Inc. Names Mark C. Miller to Board of Directors
10. 2013 ISPE Facility of the Year Awards Program Names Novartiss United States Flu Cell Culture Facility as Overall Winner
11. Pharmacy Technician Certification Board Names Linda Henson and Rico Powell as 2013 PTCB CPhT of the Year Finalists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):